CenterStar Asset Management’s AbbVie ABBV Stock Holding History

CenterStar Asset Management’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	–	Sell	-1,200	Closed	-$302K	–	218
2026 Q2	$302K	Buy	+1,200	New	+$258K	0.05%	184
2025 Q4	–	Sell	-2,000	Closed	-$463K	–	259
2025 Q3	$463K	Buy	+2,000	New	+$407K	0.1%	179
2025 Q2	–	Sell	-10,000	Closed	-$2.1M	–	196
2025 Q1	$2.1M	Buy	+10,000	New	+$1.94M	0.5%	50
2022 Q2	–	Hold	0	–	-$218K	–	386
2022 Q1	–	Hold	0	–	–	–	468
2021 Q2	–	Hold	0	–	-$550K	–	473
2021 Q1	–	Hold	0	–	–	–	283
2020 Q4	–	Hold	0	–	-$868K	–	773
2020 Q3	–	Hold	0	–	–	–	232
2020 Q2	–	Hold	0	–	–	–	165
2020 Q1	–	Hold	0	–	-$52K	–	755
2019 Q4	–	Hold	0	–	–	–	195
2019 Q3	–	Hold	0	–	–	–	440
2019 Q1	–	Hold	0	–	-$35K	–	383
2018 Q4	–	Hold	0	–	–	–	233
2018 Q3	–	Hold	0	–	–	–	193

Other funds holding ABBV

HCM

Hamlin Capital Management New York $4.04B AUM 11.59% 1-Year Est. Return

FWCM

Ferguson Wellman Capital Management Portland, Oregon $8.38B AUM 25.07% 1-Year Est. Return

MSV

MN Services Vermogensbeheer The Hague, Netherlands $13.4B AUM 37.34% 1-Year Est. Return

AIM

Artemis Investment Management Edinburgh, United Kingdom $11.5B AUM 61.77% 1-Year Est. Return

Eastern Bank Boston, Massachusetts $6.58B AUM 23.57% 1-Year Est. Return

Sapient Capital Indianapolis, Indiana $7.44B AUM 23.27% 1-Year Est. Return

Atwood & Palmer Kansas City, Missouri $1.95B AUM 16% 1-Year Est. Return

IWA

Inspirion Wealth Advisors Libertyville, Illinois $880M AUM 10.53% 1-Year Est. Return

MPWT

MassMutual Private Wealth & Trust Windsor, Connecticut $3.79B AUM 19.33% 1-Year Est. Return

FFA

Farther Finance Advisors San Francisco, California $14.2B AUM 18.33% 1-Year Est. Return

CenterStar Asset Management's ABBV Position: Q3 2023 in Review

CenterStar Asset Management sold out of AbbVie (ABBV) in Q3 2023, closing a stake of 7,695 shares — an estimated $1.04M sold.

CenterStar Asset Management first reported a position in ABBV in Q2 2023 and held it in 1 quarter. The position peaked at $1.04M in Q2 2023. 3,112 funds tracked by Wall St. Rank hold ABBV as of Q3 2023.

CenterStar Asset Management reported no remaining AbbVie position as of Q3 2023 after selling out during the quarter.
CenterStar Asset Management sold 7,695 AbbVie shares in Q3 2023, an estimated $1.04M.
CenterStar Asset Management first reported a position in AbbVie in Q2 2023 and held it in 1 quarter.
CenterStar Asset Management's AbbVie position peaked at $1.04M in Q2 2023.
3,112 funds tracked by Wall St. Rank held AbbVie as of Q3 2023.

Based on CenterStar Asset Management's 13F filing for Q3 2023, filed 19 Oct 2023.